Data capture is no longer the bottleneck, and whether the lag between a signal and a decision shrinks depends on signal design, AI governance, and vendor orchestration.
|Webcasts|May 4, 2021
Through Obstacles and Beyond: The Value of Building Strategic Site Relationships
Author(s)IQVIA
*** Wednesday, May 4, 2021 at 11am EDT *** Driving faster site activation for any clinical trial requires close interactions with sponsors to seamlessly execute a breadth of requirements to stay compliant while delivering to new levels of efficiencies ***On demand available after final airing until May 4, 2022***
Register free:
Event Overview:
The outbreak of COVID-19 has affected each of us in many ways. To develop a vaccine and successful treatments in record time after lockdown, sponsors had to adapt their clinical trial processes, site relationships and means to interact with patients. To ensure clinical trial continuity, much has been altered in the field of site setup, recruitment and unique site support.
Join this timely and insightful webcast to understand how, by leveraging a valued site setup and engagement strategy throughout the clinical development process, IQVIA has worked with sponsors to engage the right sites, provided support to sites so they remain relevant, and initiated trials in record time by incorporating innovative approaches that adapt to and overcome obstacles such as COVID-19 and other industry challenges. Learn more on
3 Key take-aways:
- The criticality of a unique site relationship is to drive efficiencies and support appropriate staffing levels while maintaining quality delivery when multiple protocols enroll at the same time
- How technology, data analytics and AI/ML are helping drive faster site activation and high-quality patient recruitment at the site and in the community
- The need to integrate clinical research as a care option for the benefit of patients, bringing to life the importance of site location, patient voice, and diversity and inclusion in clinical research
Speakers: Mark Brown, VP, Global Patient and Site Solutions, IQVIA
Christy Godwin, Global Head, Business Development, Avacare Clinical Research Network, IQVIA
Casey Orvin, SCRS President, IQVIA
Time and Date: Wednesday, May 4, 2021 at 11am EDT
On demand available after final airing until May 4, 2022.
Register free:
Related to this article
In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses what changes when AI is embedded across protocol strategy, data infrastructure, and workflow tools at once, where governance frameworks tend to fall short, and why CROs must orchestrate AI ecosystems rather than simply aggregate them.
In today’s ACT Brief, we examine what policy changes would help community and rural institutions join research, how Walmart is expanding clinical trial centers into three more states, and how FDA approved Ilumya for adults with active psoriatic arthritis.
The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
What Needs to Happen Beyond the Clinical Trial Modernization Act
3
From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions
4
Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas
5